Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • FGFR
    (2)
  • Interleukin
    (1)
TargetMol | Tags By Application
  • ELISA
    (2)
  • Functional assay
    (2)
  • FACS
    (1)
  • FCM
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

bemarituzumab

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Bemarituzumab
    FPA144
    T766731952272-74-0
    Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research.
    • $163
    In Stock
    Size
    QTY
  • Bemarituzumab (FUT8-KO)
    T9901A-491
    Bemarituzumab (FUT8-KO) is a humanized IgG1 monoclonal antibody targeting FGFR2b that lacks the FUT8 gene. The Fc domain glycan of the Bemarituzumab (FUT8-KO) antibody is devoid of core fucose, resulting in high affinity for human FcγRIIIa.
    • $192
    4-6 weeks
    Size
    QTY